. 2023; 32(1): 54-56

Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient With Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression

Elahe Pirayesh, Mehrdad Tavakoli
Department Of Nuclear Medicine, Shohadae Tajrish Medical Center, School Of Medicine, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.

A 66- year old man known case of metastatic castration resistant prostate cancer underwent successful 6 cycles treatment with 177Lu-PSMA. On the last post therapy whole body scan a new lesion in the skull was noted, suspected for disease progression. One week later, the patient complained from weakness of left upper extremity and brain MRI revealed a brain tumor, confirmed as glioblastoma pathologically.

Keywords: PSMA, mCRPC, glioblastoma, prostate cancer


Elahe Pirayesh, Mehrdad Tavakoli. Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient With Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression. . 2023; 32(1): 54-56

Corresponding Author: Elahe Pirayesh, Iran


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
Google Scholar